| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |